EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of a Commercial Fruit, Vegetable and Berry Juice Powder Concentrate on Metabolic Safety and Cardiovascular Health in Older Adults: 6-Month Results of a Randomized Controlled Trial

Tobias Ziegler iD, Azra Darko, Gerhard Ledinski, Gerd Kager, Gerd Hörl iD, Andreas Seemann, Gerhard Cvirn iD, Manfred Lamprecht

Nutrients · 2026

DOI: 10.3390/nu18172746 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Tobias Ziegler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria. Hauptthemen laut MEDLINE: Fruit, Vegetables, Fruit and Vegetable Juices, Dietary Supplements. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Green Beat (Austria), Green Beat Institute of Nutrient Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Fruit, vegetable and berry (FVB) juice powder concentrates are increasingly used to support cardiovascular health. Since they are usually consumed over long periods, this study assessed the metabolic safety of a commercial FVB supplement and its impact on selected biomarkers of systemic oxidative stress and cardiovascular health.

Methods

In this open-label, randomized controlled trial, generally healthy older adults were allocated to a control group (n = 16) or an FVB group (n = 18), ingesting six capsules/day. This work reports the pre-specified 6-month timepoint of a 1-year trial. The primary outcome, metabolic safety, was assessed by hepatic, renal, thyroid, lipid and glucose metabolism markers. Exploratory analysis assessed carbonyl proteins, malondialdehyde, and oxidized LDL as markers of systemic oxidative stress, together with homocysteine and blood pressure as markers of cardiovascular health, while plasma vitamin C served as a compliance marker.

Results

The FVB concentrate was well tolerated, and no safety-relevant deteriorations were observed in the FVB group. Carbonyl proteins decreased significantly in the FVB group (interaction p = 0.030). Homocysteine remained stable in the FVB group but increased significantly in the control group (interaction p = 0.002). Furthermore, systolic blood pressure decreased significantly (interaction p = 0.036), with a comparable interaction of diastolic blood pressure (p = 0.011), and plasma vitamin C increased significantly in the FVB group (interaction p = 0.004). After adjustment for baseline values, age and BMI, between-group differences persisted for homocysteine and diastolic blood pressure, whereas the differences in systolic blood pressure and carbonyl proteins were attenuated and no longer reached statistical significance.

Conclusions

Six months of supplementation with a commercial FVB concentrate was metabolically safe and well tolerated. Since these findings are based on a pre-specified timepoint and a limited number of participants, they are hypothesis-generating rather than confirmatory and require confirmation by the complete trial. Registered at ClinicalTrials.gov (NCT04763291; registered on 21 February 2021).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FruitVegetablesFruit and Vegetable JuicesDietary SupplementsCardiovascular DiseasesHumansOxidative StressAgedBiomarkersMaleFemaleBlood PressurePowdersHomocysteineAscorbic AcidProtein Carbonylation

Stichwörter der Autor:innen

cardiovascular riskfruit and vegetable supplementhomocysteineolder adultsoxidative stressrandomized controlled trialsafety

Substanzen

BiomarkersPowdersHomocysteineAscorbic Acid

Autor:innen und Institutionen

  • Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria.
  • Green Beat Institute of Nutrient Research, 8042 Graz, Austria.
  • Department of Human Movement Sciences, Sport and Health, University of Graz, 8010 Graz, Austria.

ORCID-Profile: Tobias Ziegler, Gerd Hörl, Gerhard Cvirn

Förderung

  • Green Beat (Austria)
  • Green Beat Institute of Nutrient Research

Zitieren

APA

Ziegler, T., Darko, A., Ledinski, G., Kager, G., Hörl, G., Seemann, A., Cvirn, G., & Lamprecht, M. (2026). Effects of a Commercial Fruit, Vegetable and Berry Juice Powder Concentrate on Metabolic Safety and Cardiovascular Health in Older Adults: 6-Month Results of a Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu18172746

Vancouver

Ziegler T, Darko A, Ledinski G, Kager G, Hörl G, Seemann A, et al. Effects of a Commercial Fruit, Vegetable and Berry Juice Powder Concentrate on Metabolic Safety and Cardiovascular Health in Older Adults: 6-Month Results of a Randomized Controlled Trial. Nutrients. 2026. doi:10.3390/nu18172746

BibTeX
@article{Ziegler2026,
  author = {Ziegler, Tobias and Darko, Azra and Ledinski, Gerhard and Kager, Gerd and Hörl, Gerd and Seemann, Andreas and Cvirn, Gerhard and Lamprecht, Manfred},
  title = {Effects of a Commercial Fruit, Vegetable and Berry Juice Powder Concentrate on Metabolic Safety and Cardiovascular Health in Older Adults: 6-Month Results of a Randomized Controlled Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18172746}
}
Kostenlos starten →